Cargando…
Mac‐2‐binding protein glycan isomer predicts all malignancies after sustained virological response in chronic hepatitis C
Despite reports of hepatocellular carcinoma (HCC) in patients with chronic hepatitis C virus (HCV) infection after achieving sustained virological response (SVR), only few studies have demonstrated the incidence of other (non‐HCC) malignancies. This study aimed to clarify the incidence, survival pro...
Autores principales: | Kawata, Kazuhito, Atsukawa, Masanori, Ohta, Kazuyoshi, Chida, Takeshi, Noritake, Hidenao, Arai, Taeang, Iwakiri, Katsuhiko, Yasuda, Satoshi, Toyoda, Hidenori, Okubo, Tomomi, Hiraoka, Atsushi, Watanabe, Tsunamasa, Uojima, Haruki, Nozaki, Akito, Tani, Joji, Morishita, Asahiro, Kageyama, Fujito, Sasada, Yuzo, Nagasawa, Masamichi, Matsushita, Masahiro, Oyaizu, Tatsuki, Mikami, Shigeru, Ikegami, Tadashi, Abe, Hiroshi, Matsuura, Kentaro, Tanaka, Yasuhito, Tsubota, Akihito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315127/ https://www.ncbi.nlm.nih.gov/pubmed/35344290 http://dx.doi.org/10.1002/hep4.1941 |
Ejemplares similares
-
Shorter pruritus period and milder disease stage are associated with response to nalfurafine hydrochloride in patients with chronic liver disease
por: Kawano, Tadamichi, et al.
Publicado: (2022) -
Real-World Clinical Application of 12-Week Sofosbuvir/Velpatasvir Treatment for Decompensated Cirrhotic Patients with Genotype 1 and 2: A Prospective, Multicenter Study
por: Atsukawa, Masanori, et al.
Publicado: (2020) -
Improved Serum Alpha-Fetoprotein Levels after Iron Reduction Therapy in HCV Patients
por: Noritake, Hidenao, et al.
Publicado: (2014) -
Sequential therapy from entecavir to tenofovir alafenamide versus continuous entecavir monotherapy for patients with chronic hepatitis B
por: Itokawa, Norio, et al.
Publicado: (2020) -
Rapid Changes in Serum Lipid Profiles during Combination Therapy with Daclatasvir and Asunaprevir in Patients Infected with Hepatitis C Virus Genotype 1b
por: Chida, Takeshi, et al.
Publicado: (2018)